Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

Completed

• Conditions: Type 1 Diabetes Mellitus; Covid19
• Interventions: Other: Online Survey

• Registration Number: NCT04558645
• Lead Sponsor: Gazi University

Brief Summary

During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-18
• Study First Submitted: 2020-09-18
• Study First Submitted QC: 2020-09-18
• Study First Posted: 2020-09-22
• Status Verified: 2020-12
• Primary Completion: 2020-12-18
• Study Completion: 2020-12-26
• Last Update Submitted: 2020-12-26
• Last Update Posted: 2020-12-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 118

Inclusion Criteria

• Having been diagnosed with Type 1 Diabetes Mellitus
• Willing to participate in the study
• Participants whose native language is Turkish

Exclusion Criteria

• Unwilling to participate in the study
• Having a cognitive disorder
• Not being literate
• Individuals who do not have sufficient knowledge and functional levels to fill out the online form

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with type 1 diabetes mellitus	Online Survey	Patients with Type 1 diabetes mellitus willing to participate in the study
Healthy controls	Online Survey	Healthy controls without chronic disease willing to participate in the study

Primary Outcome Measures

Name	Time	Method
Physical activity level	Five minutes	Physical activity level using International Physical Activity Questionnaire - Short Form (IPAQ-SF) will be evaluated.
General Quality of life	Ten minutes	Quality of life using Short Form Health Survey (SF-36) will be evaluated.

Secondary Outcome Measures

Name	Time	Method
Anxiety	Three minutes	Anxiety using Hospital Anxiety and Depression Scale will be evaluated.
Loneliness	Three minutes	Loneliness using UCLA Loneliness Scale Short Form (ULS-8) will be evaluated.
Hypoglisemia fear	Five minutes	Hypoglisemia fear using Hypoglisemia Fear Survey (HFS) will be evaluated.
Depression	Three minutes	Depression using Hospital Anxiety and Depression Scale will be evaluated.
Self-reported hypoglycemia	Last seven day	It will be questioned how many times patients have had hypoglycemic attacks (\<4 mmol/L and common symptoms) in the last 7 days.
Dyspnea	Two minutes	Dyspnea during daily life activites using Modified Medical Research Dyspnea Scale will be evaluated.

Trial Locations

Locations (1)

Zeliha ÇELİK; 🇹🇷 Ankara, Çankaya, Turkey